『Lt3001 Podcast』のカバーアート

Lt3001 Podcast

Lt3001 Podcast

無料で聴く

ポッドキャストの詳細を見る

Patients with AIS and disabling symptoms often have limited treatment options, particularly when reperfusion therapies are not feasible. LT3001 (Odatroltide), a novel molecule that enhances endogenous fibrinolysis and scavenges free radicals, was evaluated in two Phase 2 trials with distinct selection strategies

adbl_web_anon_alc_button_suppression_t1
まだレビューはありません